Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis

BACKGROUND: Anticoagulation with low molecular weight heparin and vitamin K antagonists is the current standard of care (SOC) for venous thromboembolism (VTE) treatment and prevention. Although novel oral anti-coagulants (NOACs) have been compared with SOC in this indication, no head-to-head randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, A. T., Hamilton, M., Mitchell, S. A., Phatak, H., Liu, X., Bird, A., Tushabe, D., Batson, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696796/
https://www.ncbi.nlm.nih.gov/pubmed/26716830
http://dx.doi.org/10.1371/journal.pone.0144856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696796/
https://www.ncbi.nlm.nih.gov/pubmed/26716830
http://dx.doi.org/10.1371/journal.pone.0144856

Ejemplares similares